MED1 and acute myeloid leukemia: CDK8-ChIPseq in the acute myeloid leukemia (AML) cell line of MOLM-14 cells (mixed lineage leukemia fusion MLL-AF9) has found CDK8 on super-enhancers (SE) paralleled by the binding of MED1 and BRD4.